Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Perspective Therapeutics, Inc.

NYSE: CATX · Life Sciences · 14 alerts · CIK 728387

Perspective Therapeutics, Inc. stories on ALFA USA NewsRead the news →
Share price
$0.9238Close, Nov 16
Market cap
$112M
Shares outstanding
120.76MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Perspective Therapeutics, Inc. filings on SEC EDGAR ↗

4:36 PM ET 10-Q
Financial Results

Perspective Therapeutics Q3 2026 Results: Net Loss of $32.4M, Loss Widens

Perspective Therapeutics reported a net loss of $85.4 million for the nine months ended September 30, 2026, compared to $65.6 million in the prior year period, primarily driven by increased research and development expenses. The company significantly strengthened its balance sheet through a 2026 registered offering, ending the period with $201.7 million in cash, cash equivalents, and short-term investments.

Key figure
Net loss $32.4M
4:34 PM ET 8-K
Financial Results

Perspective Therapeutics Financial Results

Perspective Therapeutics reported financial results for the third quarter ended September 30, 2026, highlighting a cash position of $202 million which is expected to fund operations into 2028. The company reported a net loss of $24.7 million for the quarter and provided clinical updates on its lead radiopharmaceutical programs, including bamzireotide navoxetan and lapemelanotide zapixetar.

Term
Q3 2026

“We have presented clinical data that demonstrated the potential of delivering alpha radiation via our proprietary targeted oncology platform. With encouraging clinical findings observed to date that further support the best‑in‑class potential of bamzireotide, continued progress across two additional programs targeting melanoma and FAP-α-positive solid tumors, and investments in our manufacturing capabilities, we are well-positioned to lead the development of the field.”

Thijs Spoor, Perspective’s Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.